Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Smriti Ojha
Multiple Sclerosis (MS) is a multifactorial disease with several physiologic and pathogenic mechanisms and pathways. In MS the immune system attacks the myelin sheath that provides insulation to the nerve cells in their brain, spinal cord and optic nerve. With the damaged and compromised nerve membrane, the nerve cells are not able to conduct electrical signals properly, resulting in limb numbness, paralysis, blindness and other neurological disorders [1-15]. The main purpose of this paper is to highlight advancements in nanotechnology that has enabled the clinician to cross blood brain barrier and to target the brain and CNS of the patient with multiple sclerosis. We have focused on application of nanotechnology having therapeutic and imaging components to improve tissue imaging, targeted interactions at molecular level, nerve protection and regeneration therapy. We have also discussed the pathophysiology of the disease and nanotechnology based new strategies to deliver the therapeutic candidates for the diagnosis and treatment of MS. Future advances in the development of new practical treatment modalities for the treatment of MS is currently a potential area of research.